Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 4Unknown 1Terminated 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Breast Neoplasms 11Prostatic Neoplasms 4Colorectal Neoplasms 4Neoplasm Metastasis 3Lymphoma 3Lung Neoplasms 3Uterine Cervical Neoplasms 2Papillomavirus Infections 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Obesity-Related Malignant Neoplasm 2Motor Activity 2Hematologic Neoplasms 2Ventricular Dysfunction, Left 1Uveal Melanoma 1Urinary Bladder Neoplasms 1Smoking Cessation 1Skin Carcinoma 1Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1No Evidence of Disease 1New Healthcare Approach 1Multiple Myeloma 1Melanoma 1Lymphoma, Non-Hodgkin 1Leukemia, Myeloid, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Kidney Neoplasms 1Inflammatory Breast Neoplasms 1Hodgkin Disease 1

Interventions

pembrolizumab 62Nivolumab 40Ipilimumab 24trametinib 13dabrafenib 10Specimen Handling 10Magnetic Resonance Spectroscopy 10binimetinib 9Cyclophosphamide 8CTLA-4 Antigen 8Biopsy 8encorafenib 7fludarabine 6Radiosurgery 6Cisplatin 6relatlimab 5cemiplimab 5atezolizumab 5Pemetrexed 5Introns 5Interleukin-2 5tislelizumab 4lenvatinib 4fludarabine phosphate 4durvalumab 4dostarlimab 4cobimetinib 4avelumab 4Radiotherapy 4Paclitaxel 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Melanoma × Methods × Clear all
NCT04611568 2026-05-22

War on Melanomaâ„¢ Public Health & Education Campaign

OHSU Knight Cancer Institute

Phase NA Active not recruiting
75,000 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡